Prognostic relevance of HER2 expression and gene amplification in estrogen receptor-positive lymph-node negative breast cancer patients

被引：0
|
作者：
Peiro, G. [1 ]
Adrover, E. [1 ]
Aranda, F. [1 ]
Alenda, C. [1 ]
Peiro, F. [1 ]
Segui, J. [1 ]
机构：
[1] Univ Alacant, Gen Hosp, Dept Pathol, Alicante, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [41] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [42] Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer
    Choi, Woo Jung
    Sim, Hayan
    Kim, Hee Jeong
    Cha, Joo Hee
    Shin, Hee Jung
    Chae, Eun Young
    Kim, Hak Hee
    ACTA RADIOLOGICA, 2021, 62 (12) : 1592 - 1600
  • [43] Hormone receptors and HER2 expression in primary tumor and synchronous axillary lymph node metastasis in estrogen receptor positive breast cancer.
    Alvarez, Isabel
    Rezola, Ricardo
    Ruiz, Irune
    Plazaola, Arrate
    Rezola, Marta
    Elorriaga, Kepa
    Lahuerta, Ainhara
    Javier Recio, Francisco
    Arestin, Maria
    Lawrie, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Domparison of prognostic value of HER2 amplification in breast cancer according to lymph node status.
    Park, YC
    Lee, A
    Kim, YS
    Oh, SJ
    Jung, SS
    Lee, JH
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S123 - S123
  • [45] Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer
    Kaklamani, Virginia G.
    Cianfrocca, Mary
    Ciccone, Jennifer
    Kindy, Kelly
    Rademaker, Alfred
    Wiley, Elizabeth L.
    Gradishar, William
    O'Regan, Ruth M.
    BIOMARKERS, 2010, 15 (02) : 191 - 193
  • [46] Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Morikawa, Aki
    Henry, N. Lynn
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3591 - 3596
  • [47] A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer
    Yue, Yuhan
    Liang, Junqing
    Wu, Yuruo
    Tong, Weibing
    Li, Dan
    Cao, Xuchen
    Wang, Xin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [48] Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
    Curigliano, Giuseppe
    Viale, Giuseppe
    Bagnardi, Vincenzo
    Fumagalli, Luca
    Locatelli, Marzia
    Rotmensz, Nicole
    Ghisini, Raffaella
    Colleoni, Marco
    Munzone, Elisabetta
    Veronesi, Paolo
    Zurrida, Stefano
    Nole, Franco
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5693 - 5699
  • [49] Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
    Min Hwan Kim
    Gun Min Kim
    Jee Hung Kim
    Jee Ye Kim
    Hyung Seok Park
    Seho Park
    Young Up Cho
    Byeong Woo Park
    Seung Il Kim
    Joohyuk Sohn
    Breast Cancer Research and Treatment, 2020, 179 : 687 - 697
  • [50] The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia
    Sakata, Shinichiro
    Cronk, Michelle
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (01) : 94 - 95
12345